Discrimination of benign and malignant human tissue during percutaneous interventions using optical spectroscopy techniques
- Conditions
- Cancer1001981510006232Malignancy10029107
- Registration Number
- NL-OMON41588
- Lead Sponsor
- Philips Research
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Completed
- Sex
- Not specified
- Target Recruitment
- 106
1) Patients with a suspicious lesion in breast, lung or liver who are scheduled for a standard core biopsy procedure
2) Patient planned for percutaneous RFA of colorectal liver metastasis
3) Written informed consent
4) Patients >= 18 years old
5) Breast patients with a BIRADS score 4 or 5
1) Patients who have high risk of bleeding
2) Patients with suspected sensitivity to light; e.g. patients who have had photodynamic therapy
3) Patients who have a history of breast cancer and/or who have received prior chemotherapy, endocrine therapy, or radiation therapy
4) Patients who have breast implants
5) Patients needing a stereotactic breast biopsy (i.e. non palpable-, ultrasound opaque lesions)
Study & Design
- Study Type
- Observational invasive
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method
Related Research Topics
Explore scientific publications, clinical data analysis, treatment approaches, and expert-compiled information related to the mechanisms and outcomes of this trial. Click any topic for comprehensive research insights.